Katherine Beebe DeVarney - 05 Jan 2022 Form 4 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)

Role
President and COO, Director
Signature
/S/ Kate Beebe Devarney
Issuer symbol
TTNP
Transactions as of
05 Jan 2022
Net transactions value
$0
Form type
4
Filing time
05 Jan 2022, 17:50:08 UTC
Next filing
28 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTNP Option to Purchase Common Stock Award $0 +55,000 $0.000000 55,000 05 Jan 2022 Common Stock 55,000 $1.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as to 27,500 shares on July 5, 2022 with the balance to vest in equal monthly installments over the 18 months thereafter.